Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 59 entries
View as:

Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00598169 Org: User:
Start: 11/30/07 End: 11/30/14 Due: 11/30/15

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01567722 Org: User:
Start: 01/02/13 End: 01/14/22 Due: 01/14/23

Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men

Phase: N/A Priority: Normal
NCT ID: NCT04142398 Org: User:
Start: 04/30/27 End: 12/31/31 Due: 12/31/32

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00324415 Org: User:
Start: 09/30/06 End: 05/31/16 Due: 05/31/17

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02797470 Org: User:
Start: 06/23/16 End: 03/31/36 Due: 03/31/37

Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00024128 Org: User:
Start: 08/31/01 End: 03/31/03 Due: 03/31/04

Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men

Phase: N/A Priority: Normal
NCT ID: NCT04142385 Org: User:
Start: 04/30/27 End: 12/31/31 Due: 12/31/32

Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02135419 Org: User:
Start: 09/24/14 End: 03/31/24 Due: 03/31/25

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00310128 Org: User:
Start: 02/28/06 End: - Due: -

Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00041327 Org: User:
Start: 10/31/02 End: 12/31/06 Due: 12/31/07

Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02137564 Org: User:
Start: 07/31/15 End: 07/31/15 Due: 07/31/16

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00389818 Org: User:
Start: 01/31/07 End: 09/30/11 Due: 09/30/12

Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00427414 Org: User:
Start: 09/30/08 End: 11/30/11 Due: 11/30/12

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT00066430 Org: User:
Start: 09/30/03 End: 04/30/06 Due: 04/30/07

Trial of Ixazomib for Kaposi Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04305691 Org: User:
Start: 11/07/23 End: 03/15/29 Due: 03/15/30

Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02418494 Org: User:
Start: 04/30/15 End: 05/31/16 Due: 05/31/17

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00513526 Org: User:
Start: 11/30/07 End: 10/31/11 Due: 10/31/12

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Phase: N/A Priority: Normal
NCT ID: NCT00667563 Org: User:
Start: 08/31/09 End: 11/30/12 Due: 11/30/13

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01590017 Org: User:
Start: 04/01/14 End: 04/20/17 Due: 04/20/18

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01775475 Org: User:
Start: 09/15/16 End: 07/15/21 Due: 07/15/22

Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus

Phase: N/A Priority: Normal
NCT ID: NCT00550589 Org: User:
Start: 09/30/07 End: 02/28/10 Due: 02/28/11

Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00450320 Org: User:
Start: 10/31/07 End: 09/30/09 Due: 09/30/10

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

Phase: N/A Priority: Normal
NCT ID: NCT01209325 Org: User:
Start: 06/28/11 End: 12/12/17 Due: 12/12/18

Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT04089488 Org: User:
Start: 01/17/20 End: 10/18/21 Due: 10/18/22

sEphB4-HSA in Treating Patients With Kaposi Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02799485 Org: User:
Start: 02/13/18 End: 02/19/25 Due: 02/19/26